A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition

BACKGROUND: The E4 isoform of apolipoprotein E (apoE4) is a major genetic risk factor for the development of sporadic Alzheimer’s disease (AD) and its modification has been an intense focus for treatment of AD in recent years. MEHTHODS: We investigated the binding of apoE, a peptide corresponding to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Biol Psychiatry
Prif Awduron: Sawmiller, Darrell, Habib, Ahsan, Hou, Huayan, Mori, Takashi, Fan, Anran, Tian, Jun, Zeng, Jin, Giunta, Brian, Sanberg, Paul R., Mattson, Mark P., Tan, Jun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6642011/
https://ncbi.nlm.nih.gov/pubmed/31208706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2019.04.026
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg